Our findings thus suggest that tumor‐intrinsic STING/NF‐κB and type I IFN signaling is critical for RA‐mediated tumor inhibition, and highlight a complex effect of RA on both cancer cells and the TME. The gene discussed is STING1; the disease is neoplasm.